Clinical Trial Update: Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating stereotactic body radiation therapy (SBRT) in patients with oligoprogressive metastatic breast and lung cancers. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: TNBC - Triple-Negative Breast Cancer, Triple Negative Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING